A physicochemical approach for predicting the effectiveness of peptide-based gene delivery systems for use in plasmid-based gene therapy
- PMID: 9635734
- PMCID: PMC1299621
- DOI: 10.1016/S0006-3495(98)77987-1
A physicochemical approach for predicting the effectiveness of peptide-based gene delivery systems for use in plasmid-based gene therapy
Abstract
Novel synthetic peptides, based on carrier peptide analogs (YKAKnWK) and an amphipathic peptide (GLFEALLELLESLWELLLEA), have been formulated with DNA plasmids to create peptide-based gene delivery systems. The carrier peptides are used to condense plasmids into nanoparticles with a hydrodynamic diameter (DH) ranging from 40 to 200 nm, which are sterically stable for over 100 h. Size and morphology of the carrier peptide/plasmid complex have been determined by photon correlation spectroscopy (PCS) and transmission electron microscopy (TEM), respectively. The amphipathic peptide is used as a pH-sensitive lytic agent to facilitate release of the plasmid from endosomes after endocytosis of the peptide/plasmid complex. Hemolysis assays have shown that the amphipathic peptide destabilizes lipid bilayers at low pH, mimicking the properties of viral fusogenic peptides. However, circular dichroism studies show that unlike the viral fusion peptides, this amphipathic peptide loses some of its alpha-helical structure at low pH in the presence of liposomes. The peptide-based gene delivery systems were tested for transfection efficiency in a variety of cell lines, including 14-day C2C12 mouse myotubes, using gene expression systems containing the beta-galactosidase reporter gene. Transfection data demonstrate a correlation between in vitro transfection efficiency and the combination of several physical properties of the peptide/plasmid complexes, including 1) DNA dose, 2) the zeta potential of the particle, 3) the requirement of both lytic and carrier peptides, and 4) the number of lysine residues associated with the carrier peptide. Transfection data on 14-day C2C12 myotubes utilizing the therapeutic human growth hormone gene formulated in an optimal peptide gene delivery system show an increase in gene expression over time, with a maximum in protein levels at 96 h (approximately 18 ng/ml).
Similar articles
-
Insight into the role of physicochemical parameters in a novel series of amphipathic peptides for efficient DNA delivery.Mol Pharm. 2013 Jul 1;10(7):2588-600. doi: 10.1021/mp400032q. Epub 2013 Jun 3. Mol Pharm. 2013. PMID: 23725377
-
Improved intracellular delivery of peptide- and lipid-nanoplexes by natural glycosides.J Control Release. 2015 May 28;206:75-90. doi: 10.1016/j.jconrel.2015.03.007. Epub 2015 Mar 7. J Control Release. 2015. PMID: 25758332
-
Histidine-rich cationic amphipathic peptides for plasmid DNA and siRNA delivery.Methods Mol Biol. 2013;948:85-103. doi: 10.1007/978-1-62703-140-0_7. Methods Mol Biol. 2013. PMID: 23070765
-
GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery.Adv Drug Deliv Rev. 2004 Apr 23;56(7):967-85. doi: 10.1016/j.addr.2003.10.041. Adv Drug Deliv Rev. 2004. PMID: 15066755 Review.
-
Cationic amphipathic histidine-rich peptides for gene delivery.Biochim Biophys Acta. 2006 Mar;1758(3):301-7. doi: 10.1016/j.bbamem.2006.02.005. Epub 2006 Feb 28. Biochim Biophys Acta. 2006. PMID: 16540079 Review.
Cited by
-
Development of an effective gene delivery system: a study of complexes composed of a peptide-based amphiphilic DNA compaction agent and phospholipid.Nucleic Acids Res. 2001 Sep 1;29(17):3694-704. doi: 10.1093/nar/29.17.3694. Nucleic Acids Res. 2001. PMID: 11522841 Free PMC article.
-
Structure of transfection-active histone H1/DNA complexes.Mol Biol Rep. 2001;28(3):157-65. doi: 10.1023/a:1015230010230. Mol Biol Rep. 2001. PMID: 12075934
-
Novel molecular approaches to cystic fibrosis gene therapy.Biochem J. 2005 Apr 1;387(Pt 1):1-15. doi: 10.1042/BJ20041923. Biochem J. 2005. PMID: 15656784 Free PMC article. Review.
-
The effect of PS content on the ability of natural membranes to fuse with positively charged liposomes and lipoplexes.J Membr Biol. 2005 Aug;206(3):203-14. doi: 10.1007/s00232-005-0793-0. J Membr Biol. 2005. PMID: 16456715
-
Engineered Polymeric Materials for Biological Applications: Overcoming Challenges of the Bio-Nano Interface.Polymers (Basel). 2019 Sep 2;11(9):1441. doi: 10.3390/polym11091441. Polymers (Basel). 2019. PMID: 31480780 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical